New Fellowship in Policy Impact of Comparative Effectiveness Research Available Through a Partnership of the National Pharmaceutical Council and The George Washington University School of Public Health and Health Services
Applications Being Accepted Now for Two-Year Program
WASHINGTON, Oct. 23, 2012 /PRNewswire-USNewswire/ — The National Pharmaceutical Council (NPC), in conjunction with The George Washington University School of Public Health and Health Services (SPHHS), is now accepting applications for a new Post-Doctoral Fellow to address the policy implications of comparative effectiveness research (CER).
“This Fellowship offers a unique opportunity to bridge the gap between health care policy and comparative effectiveness research,” said NPC Chief Science Officer Robert Dubois, MD, PhD. “NPC is excited at the opportunity to collaborate with the George Washington University on this program that will raise awareness of the policy implications of CER.”
This newly created fellowship opportunity aims to combine training in CER and CER programs with an increased understanding of related health care policy. In recent years, public and private funding for CER has dramatically increased, with the intention of providing useful information to help patients and providers make informed healthcare and treatment decisions. Although there are many academic programs that train researchers in how to conduct and apply CER, and there are many programs that focus on understanding and developing health care policy, there are very few programs that bring these two areas together. In an effort to bridge this gap and to raise awareness and understanding of the policy implications of CER, the NPC joined SPHHS to create this new post-doctoral Fellowship in the Policy Impact of Comparative Effectiveness Research.
The NPC/SPHHS Fellowship in the Policy Impact of CER is open to post-doctoral researchers with a desire to understand and study the policy impact of CER. Candidates should be U.S. citizens or permanent residents, and be within five years of having completed their doctoral degree. The Fellow would be an employee of NPC and would have an adjunct faculty appointment in the SPHHS Department of Health Policy.
“The new fellowship fits well with the mission of the Department of Health Policy, which is to conduct rigorous, multidisciplinary research that addresses significant health policy challenges, and that also takes advantage of our strategic location in Washington, D.C.,” stated Paula Lantz, PhD, professor and chair of the department. “We are pleased that the fellows’ experience will be enhanced by their connections with SPHHS.”
For more information about the Fellowship and to apply, visit www.npcnow.org/fellowship. Applications are being accepted now and up until the position is filled. The fellowship will run from July 2013 to June 2015.
About the National Pharmaceutical Council:
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation’s major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.
About the George Washington University School of Public Health and Health Services:
Established in July 1997, the School of Public Health and Health Services brought together three longstanding university programs in the schools of medicine, business, and education that we have since expanded substantially. Today, more than 1,100 students from nearly every U.S. state and more than 40 nations pursue undergraduate, graduate, and doctoral-level degrees in public health. Our student body is one of the most ethnically diverse among the nation’s private schools of public health. http://sphhs.gwu.edu/
SOURCE National Pharmaceutical Council